In 2024, three leading researchers were recognized by Time Magazine as among the 100 most influential people in the world. Professor Daniel Joshua Drucker, Professor Joel Francis Habener, and Associate Professor Svetlana Mojsov were honored for their work on weight loss drugs. The trio was acknowledged for their collective efforts in researching and developing effective treatments for diabetes and obesity.
Their groundbreaking discoveries led to the identification of a crucial link between insulin and incretins, specifically GLP-1, which plays a key role in controlling blood sugar levels and weight. Their work has paved the way for innovative treatments that have been approved in the US for treating diabetes and obesity, with potential applications in reducing the risk of cardiovascular diseases.
In addition to their accolades from Time Magazine, these researchers received the VinFuture Awards for their revolutionary work on GLP-1. This recognition underscores the importance of their pioneering contributions to healthcare, which have shaped the future of treatment for various diseases.
Associate Professor Svetlana Mojsov’s significant role in synthesizing GLP-1 and developing antibodies against it was instrumental in advancing our understanding of GLP-1 and its impact on insulin levels. Her contributions were essential in shaping the development of drugs like Ozempic, Wegovy, Mounjaro, and Zepbound.
Ongoing research continues to explore further uses of these drugs in combating Alzheimer’s disease, Parkinson’s disease, kidney diseases, and liver disease. The recognition of Associate Professor Mojsov by Time Magazine highlights her important work that has often been overlooked by major international biomedical awards. This acknowledgment aligns with the comprehensive evaluation criteria of the VinFuture Award, highlighting the groundbreaking contributions of these scientists.
Overall, this group of researchers has made significant advancements in healthcare through their dedication to scientific research and innovation. Their pioneering work has shaped the future of treatment for various diseases and continues to inspire new developments that will improve human health worldwide.